Completed
NCT Number: NCT02931461
Interest of Procore Needle® for Diagnosis of Lung Cancer
The ProCore ultrasound biopsy needle, used primarily to obtain intra-abdominal tissue core biopsies, has not been widely used for endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). In this study the investigators are going to evaluate the utility of the ProCore needle for sampling mediastinal or hilar lymph nodes during EBUS-TBNA versus standard 22 gauge needle for diagnosis of lung cancer.
Completed
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- mediastinal lymphadenopathy >10 millimeters
- lung cancer suspected
Exclusion criteria
- coagulopathy contraindication for midazolam contraindication for bronchoscopy
Treatment and study plan
Primary outcomes
-
Proportion of histological diagnoses for each needle
Time frame: 6 months
Sponsors and collaborators
Lead sponsor
Poitiers University Hospital
Other
Registry information
Important dates
- Study start
- 2016
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Oct 13, 2016
- Registry last updated
- Jun 2, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.